Cycloset Approved for Type 2 Diabetes
By Drugs.com
May 7, 2009
271
1
WEDNESDAY, May 6 — Cycloset (bromocriptine), a drug that takes the novel approach of managing blood sugar via the brain, has been approved by the U.S. Food and Drug Administration, maker VeroScience Inc. said Wednesday.
The drug, previously prescribed in higher amounts to treat Parkinson's disease, targets a brain chemical that ultimately is involved in regulating metabolism, reports the Associated Press.
A single dose taken in the morning helped control the rise in blood sugar that typically …(more)
Like




Comments (No comments)
Add your commentAsk questions, get answers.
Give the community your two cents.
Be the first by adding your comments.